Plain-English translation of NCT05196334 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Pancreatic Cancer research guide →This trial is testing a new way to personalize pancreatic cancer treatment. Researchers will collect a small tissue sample from your pancreas during a routine biopsy, then grow those cancer cells in the laboratory and test them against different medications to see which ones work best against your specific cancer. This information could help your doctors choose the most effective treatment for you.
Pancreatic cancer is difficult to treat because every patient's cancer is different, and doctors often don't know which medication will work best before starting treatment. This study aims to solve that problem by testing your individual cancer cells against available drugs first, so your doctors can make a more informed choice about which treatment to give you.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will undergo a standard biopsy procedure (endoscopic ultrasound-guided needle biopsy) to collect a small tissue sample from your pancreas—this is likely already part of your normal diagnostic care. After the biopsy, researchers will take that tissue sample and grow cancer cells from it in the laboratory, then test those cells against six to ten different medications used to treat pancreatic cancer. You'll also have CT scans of your chest and abdomen at the start of the study to help measure how well your actual treatment works. Your doctors will continue your regular cancer care based on current treatment standards, and the information from your tissue testing may help guide those treatment decisions.
AI-generated summary from trial data · Jul 6, 2026 · Not medical advice
Denmark
Sponsor
Herlev Hospital
Collaborators
Rigshospitalet, Denmark
Enrollment target
~88 participants
Started
July 2021
Primary completion
August 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in October 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Pia H Klausen, PhD
Rigshospitalet, Denmark
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.